Clinical Hours: Mon-Fri, 8AM - 3PM(905) 493-5700
1885 Glenanna Road, Suite 220, Pickering, ON, L1V 6R6
Dermatofibroma is a common benign firm skin nodule, typically on the lower legs, requiring specialist evaluation to differentiate from other dermal lesions.
Dermatofibroma (also known as benign fibrous histiocytoma) is one of the most common benign skin lesions encountered in dermatological practice. It presents as a firm, dome-shaped papule or nodule in the dermis, most frequently found on the lower extremities. Dermatofibromas are composed of a proliferation of fibroblasts and histiocytes and are entirely benign with no significant malignant potential.
Dermatofibromas are extremely common and can occur at any age, although they are most frequently diagnosed in young to middle-aged adults. The condition affects women more commonly than men. Most individuals present with a solitary lesion, although multiple dermatofibromas may occasionally occur, particularly in immunosuppressed patients.
The exact cause of dermatofibromas is not fully understood. They are thought to represent a localised fibrous tissue reaction, possibly triggered by minor trauma to the skin. The lesion consists of a proliferation of dermal fibroblasts, myofibroblasts, and histiocytes, with secondary changes including increased collagen deposition, haemosiderin (iron pigment) accumulation, and overlying epidermal hyperplasia.
Factors associated with dermatofibroma development include:
Dermatofibromas are not caused by infection, are not contagious, and are not related to skin cancer.
Dermatofibromas present with characteristic clinical features that often allow identification on examination:
Dermatofibromas are stable lesions that persist indefinitely. They do not resolve spontaneously but also do not grow progressively. Sudden change in size, bleeding, or ulceration is not typical of a dermatofibroma and warrants further evaluation.
Dermatofibromas are usually diagnosed clinically based on their characteristic appearance, firm texture, and positive dimple sign. Dermoscopy reveals a distinctive pattern consisting of a central white scar-like area (or white network) surrounded by a peripheral delicate pigment network. This dermoscopic pattern is highly specific for dermatofibroma and helps differentiate it from melanocytic lesions.
A skin biopsy may be performed when the clinical or dermoscopic appearance is atypical, when the lesion is growing, or when the diagnosis is uncertain. Histopathology demonstrates a well-circumscribed but unencapsulated dermal proliferation of fibroblasts and histiocytes arranged in a storiform (cartwheel) pattern, with peripheral collagen trapping at the margins.
The differential diagnosis includes melanoma (particularly when the lesion is darkly pigmented), dermatofibrosarcoma protuberans (DFSP, a locally aggressive fibroblastic tumour that may initially resemble a dermatofibroma but tends to be larger and infiltrative), hypertrophic scar, and keloid. Specialist evaluation ensures appropriate differentiation and avoids unnecessary concern or missed diagnoses.
Dermatofibromas are benign and do not require treatment in most cases. Once the diagnosis is confirmed, reassurance and observation are appropriate for the majority of patients. Treatment may be considered when a lesion is symptomatic (tender or pruritic), cosmetically undesirable, or when the diagnosis remains uncertain.
Complete surgical excision is the definitive treatment for dermatofibromas. Because dermatofibromas extend into the deep dermis and sometimes the subcutaneous fat, full-thickness excision is necessary to prevent recurrence. This results in a linear scar that is typically longer than the original lesion, and patients should be counselled about this trade-off before proceeding. Excision also provides tissue for histopathological examination, which is valuable when the diagnosis is in doubt.
Shave removal flattens the lesion to the level of the surrounding skin and provides a specimen for histological examination. However, because the deeper portion of the lesion remains in situ, recurrence is common with this approach. Shave removal may be a reasonable option for patients who wish to reduce the prominence of a lesion without undergoing a full excision.
Cryotherapy with liquid nitrogen may flatten and reduce the size of a dermatofibroma but does not eliminate the lesion. It can improve cosmetic appearance in some cases but carries a risk of hypopigmentation, particularly on darker skin tones.
Dermatological assessment is recommended for any firm skin nodule to confirm the diagnosis and exclude other conditions. Evaluation is particularly important when a lesion is growing, painful, bleeding, ulcerated, or larger than one centimetre in diameter, as these features may suggest an alternative diagnosis. The development of multiple dermatofibromas may warrant investigation for underlying immunosuppression.
A referral from a family physician is the standard pathway to access specialist dermatology care. Dr. Maksym Breslavets at the Centre for Medical and Surgical Dermatology provides specialist evaluation and management of dermatofibromas, including dermoscopic assessment, diagnostic biopsy, and surgical excision when indicated.
Your feedback helps us improve our condition information
A physician referral is required to access our medical services. Contact your primary care provider to begin the referral process.